Date | Time | Source | Headline | Symbol | Company |
11/30/2023 | 7:30AM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/27/2023 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/27/2023 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 5:09PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 5:07PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 5:05PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 5:03PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 5:03PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 5:01PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:51PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:43PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:42PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:41PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:41PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:40PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:39PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:39PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:38PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:38PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:37PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:37PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:35PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:32PM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:31PM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 4:26PM | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/20/2023 | 8:49AM | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | USOTC:ACER | Acer Therapeutics Inc (PK) |
11/14/2023 | 6:04AM | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | USOTC:ACER | Acer Therapeutics Inc (PK) |
01/03/2020 | 4:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:ACER | Acer Therapeutics Inc (PK) |
01/03/2020 | 4:17PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:ACER | Acer Therapeutics Inc (PK) |
01/03/2020 | 4:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:ACER | Acer Therapeutics Inc (PK) |